BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 24832165)

  • 21. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
    Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
    Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: SWI/SNF-deficient Sinonasal Neoplasms: An Overview.
    Agaimy A
    Head Neck Pathol; 2022 Mar; 16(1):168-178. PubMed ID: 35307773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SMARCB1 (INI-1)-Deficient Adenocarcinoma of the Sinonasal Tract: A Potentially Under-Recognized form of Sinonasal Adenocarcinoma with Occasional Yolk Sac Tumor-Like Features.
    Shah AA; Jain D; Ababneh E; Agaimy A; Hoschar AP; Griffith CC; Magliocca KR; Wenig BM; Rooper LM; Bishop JA
    Head Neck Pathol; 2020 Jun; 14(2):465-472. PubMed ID: 31468350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. INI1 (SMARCB1)-Deficient Sinonasal Carcinoma: A Clinicopathologic Report of 2 Cases.
    Wasserman JK; Dickson BC; Perez-Ordonez B; de Almeida JR; Irish JC; Weinreb I
    Head Neck Pathol; 2017 Jun; 11(2):256-261. PubMed ID: 27644951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary high-grade myoepithelial carcinoma of the lung: A study of three cases illustrating frequent SMARCB1-deficiency and review of the literature.
    Agaimy A; Naroditsky I; Ben-Izhak O
    Ann Diagn Pathol; 2021 Aug; 53():151759. PubMed ID: 34111706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization.
    Kezlarian BE; Lin O; Dogan S
    J Am Soc Cytopathol; 2020; 9(6):494-501. PubMed ID: 32839151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features.
    Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY
    Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SMARCA4-deficient Sinonasal Carcinoma.
    Agaimy A; Weichert W
    Head Neck Pathol; 2017 Dec; 11(4):541-545. PubMed ID: 28176137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMARCB1-deficient sinonasal adenocarcinoma: a rare variant of SWI/SNF-deficient malignancy often misclassified as high-grade non-intestinal-type sinonasal adenocarcinoma or myoepithelial carcinoma.
    Skálová A; Taheri T; Bradová M; Vaněček T; Franchi A; Slouka D; Kostlivý T; de Rezende G; Michálek J; Klubíčková N; Ptáková N; Nemcová A; Michal M; Agaimy A; Leivo I
    Virchows Arch; 2023 Dec; ():. PubMed ID: 38085333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.
    Agaimy A; Daum O; Märkl B; Lichtmannegger I; Michal M; Hartmann A
    Am J Surg Pathol; 2016 Apr; 40(4):544-53. PubMed ID: 26551623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMARCB1-deficient Vulvar Neoplasms: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 14 Cases.
    Folpe AL; Schoolmeester JK; McCluggage WG; Sullivan LM; Castagna K; Ahrens WA; Oliva E; Biegel JA; Nielsen GP
    Am J Surg Pathol; 2015 Jun; 39(6):836-49. PubMed ID: 25651469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes.
    Agaimy A; Haller F; Frohnauer J; Schaefer IM; Ströbel P; Hartmann A; Stoehr R; Klöppel G
    Mod Pathol; 2015 Feb; 28(2):248-60. PubMed ID: 25103069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience.
    Bell D; Hanna EY; Agaimy A; Weissferdt A
    Virchows Arch; 2015 Dec; 467(6):649-656. PubMed ID: 26407663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myoepithelioma-like Tumors of the Vulvar Region: A Distinctive Group of SMARCB1-deficient Neoplasms.
    Yoshida A; Yoshida H; Yoshida M; Mori T; Kobayashi E; Tanzawa Y; Yasugi T; Kawana K; Ishikawa M; Sugiura H; Maeda D; Fukayama M; Kawai A; Hiraoka N; Motoi T
    Am J Surg Pathol; 2015 Aug; 39(8):1102-13. PubMed ID: 26171919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y
    Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SMARCB1/INI1-deficient pancreatic undifferentiated rhabdoid carcinoma mimicking solid pseudopapillary neoplasm: A case report and review of the literature.
    Hua Y; Soni P; Larsen D; Zreik R; Leng B; Rampisela D
    World J Gastroenterol; 2020 Sep; 26(36):5520-5526. PubMed ID: 33024402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SMARCB1-Deficient Sinonasal Carcinoma: Case Report and Review of the Literature.
    AlMadan NM; AlEssa EA; AlGhamdi DA
    Am J Case Rep; 2023 May; 24():e939244. PubMed ID: 37198880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SMARCB1 (INI1)-Deficient Sinonasal Carcinoma with Yolk Sac differentiation Showing Co-loss of SMARCA4 Immunostaining - A Case Report and Literature Review.
    Ng JKM; Chan JYK; Li JJX; Tang K; Yeung DCM; Chan ABW
    Head Neck Pathol; 2022 Sep; 16(3):934-941. PubMed ID: 35257325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRG1, INI1, and ARID1B Deficiency in Endometrial Carcinoma: A Clinicopathologic and Immunohistochemical Analysis of a Large Series From a Single Institution.
    Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
    Am J Surg Pathol; 2020 Dec; 44(12):1712-1724. PubMed ID: 32910019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
    Ramalingam P; Croce S; McCluggage WG
    Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.